All products / DC47928
PCC0208017
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $700 USDRequest a quote / confirm availability → |
| 250 mg | $1,200 USDRequest a quote / confirm availability → |
| 1 g | $2,400 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
PCC0208017 is a microtubule affinity regulating kinases (MARK3/MARK4) inhibitor with IC50s of 1.8 and 2.01 nM, respectively. PCC0208017 has much lower inhibitory activity against MARK1 and MARK2, with IC50s of 31.4 and 33.7 nM, respectively. PCC0208017 suppresses glioma progression in vitro and in vivo. PCC0208017 disrupts microtubule dynamics and induces G2/M phase cell cycle arrest and cell apoptosis. PCC0208017 demonstrates robust antitumor activity in vivo and displays good BBB permeability.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC47928 |
|---|---|
| Product name | PCC0208017 |
| CAS | 2623158-64-3 |
| Molecular formula | C19H20F3N7 |
| Molecular weight | 403.4 |
| Purity | >98% |
| SMILES | CN1CCc2cc(Nc3ncc(C(F)(F)F)c(NCc4cc[nH]n4)n3)ccc2C1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — PCC0208017 (DC47928)